These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26695077)

  • 1. Complement and Cardiovascular Disease--The Missing Link in Haemodialysis Patients.
    Lines SW; Richardson VR; Thomas B; Dunn EJ; Wright MJ; Carter AM
    Nephron; 2016; 132(1):5-14. PubMed ID: 26695077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients.
    Poppelaars F; Gaya da Costa M; Faria B; Berger SP; Assa S; Daha MR; Medina Pestana JO; van Son WJ; Franssen CFM; Seelen MA
    Front Immunol; 2018; 9():2070. PubMed ID: 30271407
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Membrane Permeability on Cardiovascular Risk Factors and β2m Plasma Levels in Patients on Long-Term Haemodialysis: A Randomised Crossover Trial.
    Chazot C; Kirchgessner J; Pham J; Vo-Van C; Lorriaux C; Hurot JM; Zaoui E; Grassmann A; Jean G; Marcelli D
    Nephron; 2015; 129(4):269-75. PubMed ID: 25825336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
    Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
    Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients.
    Poppelaars F; Gaya da Costa M; Berger SP; Assa S; Meter-Arkema AH; Daha MR; van Son WJ; Franssen CF; Seelen MA
    J Transl Med; 2016 Aug; 14(1):236. PubMed ID: 27495980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial evaluating the erythropoiesis stimulating agent sparing potential of a vitamin E-bonded polysulfone dialysis membrane.
    Lines SW; Carter AM; Dunn EJ; Lindley EJ; Tattersall JE; Wright MJ
    Nephrol Dial Transplant; 2014 Mar; 29(3):649-56. PubMed ID: 24293660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
    Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
    J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
    Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
    J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.
    Kirmizis D; Papagianni A; Belechri AM; Memmos D
    Nephrol Dial Transplant; 2011 Jul; 26(7):2296-301. PubMed ID: 21127134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients.
    João Matias P; Azevedo A; Laranjinha I; Navarro D; Mendes M; Ferreira C; Amaral T; Jorge C; Aires I; Gil C; Ferreira A
    Blood Purif; 2014; 38(3-4):244-52. PubMed ID: 25573320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
    Terrier N; Jaussent I; Dupuy AM; Morena M; Delcourt C; Chalabi L; Rouanet C; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2008 Jan; 23(1):345-53. PubMed ID: 17890748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
    Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT
    Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients.
    Mizuno M; Suzuki Y; Higashide K; Sei Y; Iguchi D; Sakata F; Horie M; Maruyama S; Matsuo S; Morgan BP; Ito Y
    PLoS One; 2017; 12(1):e0169111. PubMed ID: 28046064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetuin A/nutritional status predicts cardiovascular outcomes and survival in hemodialysis patients.
    Chen HY; Chiu YL; Hsu SP; Pai MF; Yang JY; Peng YS
    Am J Nephrol; 2014; 40(3):233-41. PubMed ID: 25322785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.